Life sciences manufacturing can be an economic lifeline
The state must seize the opportunity to lead
By 
Jon Santiago and Jake Auchincloss
COVID-19, drug development, pharmaceutical manufacturing
0 Comments
ALREADY, THE ECONOMIC damage done to Massachusetts by the COVID-19 recession is rivaling the Great Depression. Unemployment rates and tax revenue shortfalls are expected to be three times worse than the Great Recession. More workers filed unemployment claims in the first three weeks of the current lockdown than in all of the 2008 economic downturn.(...)